Dashboard
Manage Tickers

CNMD


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

piper-sandler-maintains-overweight-on-conmed-lowers-price-target-to-68
Piper Sandler Maintains Overweight on Conm...
07/31/2025 13:55:51

Piper Sandler analyst Matt O'Brien maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $80 t...

conmed-lowers-fy2025-adj-eps-guidance-from-445-460-to-440-455-vs-439-est-raises-fy2025-sales-guidance-from-1350b-1378b-to-1356b-1378b-vs-1362b-est
Conmed Lowers FY2025 Adj EPS Guidance from...
07/30/2025 21:05:34

Conmed (NYSE:CNMD) lowers FY2025 Adj EPS guidance from $4.45-$4.60 to $4.40-$4.55 vs $4.39 analyst estimate. Raises FY2025 sale...

conmed-q2-adj-eps-115-beats-112-estimate-sales-342345m-beat-338167m-estimate
Conmed Q2 Adj. EPS $1.15 Beats $1.12 Estim...
07/30/2025 20:06:39

Conmed (NYSE:CNMD) reported quarterly earnings of $1.15 per share which beat the analyst consensus estimate of $1.12 by 2.4 per...

Core News & Articles
Earnings Scheduled For July 30, 2025
07/30/2025 08:32:48

merit-medical-names-medtronic-veteran-martha-aronson-as-next-ceo-projects-strong-outlook
Merit Medical Names Medtronic Veteran Mart...
07/08/2025 12:34:54

Merit Medical appoints Medtronic veteran Martha Aronson as CEO, projecting strong Q2 revenue above estimates.

this-conagra-brands-analyst-turns-bearish-here-are-top-3-downgrades-for-thursday
This Conagra Brands Analyst Turns Bearish;...
06/12/2025 13:10:43

demystifying-conmed-insights-from-5-analyst-reviews
Demystifying Conmed: Insights From 5 Analy...
06/12/2025 13:00:48

needham-downgrades-conmed-to-hold-maintains-price-target-to-61
Needham Downgrades Conmed to Hold, Maintai...
06/12/2025 12:32:17

Needham analyst Mike Matson downgrades Conmed (NYSE:CNMD) from Buy to Hold and maintains the price target from $61 to $61.

conmed-appoints-laverne-council-to-succeed-martha-goldberg-aronson-as-independent-chair-of-the-board-of-directors-effective-may-21-2025
CONMED Appoints Laverne Council To Succeed...
05/21/2025 11:17:53

jp-morgan-maintains-neutral-on-conmed-lowers-price-target-to-58
JP Morgan Maintains Neutral on Conmed, Low...
05/01/2025 17:47:44

JP Morgan analyst Robbie Marcus maintains Conmed (NYSE:CNMD) with a Neutral and lowers the price target from $70 to $58.

cvs-health-posts-better-than-expected-earnings-joins-commscope-microsoft-meta-chart-industries-and-other-big-stocks-moving-higher-on-thursday
CVS Health Posts Better-Than-Expected Earn...
05/01/2025 15:36:36

wells-fargo-maintains-equal-weight-on-conmed-lowers-price-target-to-57
Wells Fargo Maintains Equal-Weight on Conm...
05/01/2025 15:28:35

Wells Fargo analyst Vik Chopra maintains Conmed (NYSE:CNMD) with a Equal-Weight and lowers the price target from $70 to $57.

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/01/2025 12:05:58

breaking-down-conmed-6-analysts-share-their-views
Breaking Down Conmed: 6 Analysts Share The...
05/01/2025 12:00:33

needham-maintains-buy-on-conmed-lowers-price-target-to-61
Needham Maintains Buy on Conmed, Lowers Pr...
05/01/2025 11:59:05

Needham analyst Mike Matson maintains Conmed (NYSE:CNMD) with a Buy and lowers the price target from $91 to $61.

correction-conmed-q1-adj-eps-095-beats-081-estimate-sales-32130m-beat-31337m-estimate
CORRECTION: Conmed Q1 Adj. EPS $0.95 Beats...
04/30/2025 22:17:19

Conmed (NYSE:CNMD) reported quarterly earnings of $0.95 per share which beat the analyst consensus estimate of $0.81 by 17.28 p...

conmed-raises-fy2025-adj-eps-guidance-from-425-440-to-445-460-vs-434-est-raises-fy2025-sales-guidance-from-134b-137b-to-135b-138b-vs-136b-est
Conmed Raises FY2025 Adj EPS Guidance from...
04/30/2025 20:23:42

Conmed (NYSE:CNMD) raises FY2025 Adj EPS guidance from $4.25-$4.40 to $4.45-$4.60 vs $4.34 analyst estimate. Raises FY2025 sale...

Core News & Articles
Earnings Scheduled For April 30, 2025
04/30/2025 08:32:41

stifel-downgrades-conmed-to-hold-lowers-price-target-to-55
Stifel Downgrades Conmed to Hold, Lowers P...
04/28/2025 15:04:30

Stifel analyst Rick Wise downgrades Conmed (NYSE:CNMD) from Buy to Hold and lowers the price target from $75 to $55.

breaking-down-conmed-4-analysts-share-their-views
Breaking Down Conmed: 4 Analysts Share The...
02/06/2025 21:00:19

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION